Jörgen Elgqvist (Former)
1 – 7 of 7
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2019
- 
                        Mark
        Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics
    
    - Contribution to journal › Article
 
- 2016
- 
                        Mark
        Radioimmunotherapy for Prostate Cancer-Current Status and Future Possibilities.
    
    - Contribution to journal › Scientific review
 
- 
                        Mark
        Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide 177Lu Compared to Alpha Particles and Gamma Rays.
    
    - Contribution to journal › Article
 
- 
                        Mark
        Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide ¹⁷⁷Lu Compared to Alpha Particles and Gamma Rays
    
    - Contribution to journal › Article
 
- 
                        Mark
        High resolution digital autoradiographic and dosimetric analysis of heterogeneous radioactivity distribution in xenografted prostate tumors
    
    - Contribution to journal › Article
 
- 2015
- 
                        Mark
        Cancer Cell Radiobiological Studies Using In-House-Developed α-Particle Irradiator.
    
    - Contribution to journal › Article
 
- 
                        Mark
        Radioimmunoimaging and Radioimmunotherapy of Prostate Cancer. Preclinical evaluation of kallikrein related peptidase 2 targeting
    
    - Contribution to journal › Published meeting abstract
 
